Who has invested in Summit Therapeutics?

Akeso, Inc. are named among the investors backing Summit Therapeutics.

Summit Therapeutics Funding: $50M Raised, Growth (2019)

Summit Therapeutics funding overview

Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom. Summit Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in December 2019. The round record for Summit Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Akeso, Inc..

Summit Therapeutics at a glance

Total raised: $50M
Latest round: Growth
Latest round date: December 2019
Headquarters: Abingdon, Oxfordshire, United Kingdom
Notable investors: Akeso, Inc.

Frequently asked about Summit Therapeutics funding

How much has Summit Therapeutics raised?: Summit Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Summit Therapeutics?: Akeso, Inc. are named among the investors backing Summit Therapeutics.
What was the latest Summit Therapeutics funding round?: The most recent disclosed round is a Growth, announced in December 2019.
Where is Summit Therapeutics based?: Summit Therapeutics is based in Abingdon, Oxfordshire, United Kingdom.
When did Summit Therapeutics last raise?: The last disclosed Summit Therapeutics round closed in December 2019 at Growth.

Round data for Summit Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Abingdon and backer lists below.

Summit Therapeutics Funding: $50M Raised, Growth (2019)

Summit Therapeutics funding overview

Summit Therapeutics at a glance

Frequently asked about Summit Therapeutics funding

Companies related to Summit Therapeutics (34)

Browse related funding lists (3)